RxSight, Inc. logo RXST - RxSight, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $10.25 DETAILS
HIGH: $11.00
LOW: $9.00
MEDIAN: $10.50
CONSENSUS: $10.25
UPSIDE: 68.45%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 30.9 32.6 30.3 33.6 37.9 40.2 45.4 34.9 29.5 28.6 30.7 20.8 17.5 16.1 12.6 11.4 8.9 8.4 5.8 4.9 3.5 4.9 4.2 2.7 2.9
Cost of Revenue 7.4 7.3 6.1 8.4 9.6 11.4 20.2 10.6 8.8 10.9 16.9 8.8 7.1 8.7 7.3 6.6 5.2 5.6 4.4 5.7 2.4 3.5 3.5 3.2 2.8
Gross Profit 23.5 25.3 24.2 25.2 28.3 28.8 25.2 24.2 20.7 17.7 13.7 12.0 10.4 7.4 5.4 4.8 3.8 2.9 1.3 (0.8) 1.1 1.4 0.7 (0.5) 0.1
Operating Expenses
R&D Expenses 9.5 8.9 9.1 10.2 10.4 9.2 8.8 8.3 8.0 7.3 7.1 7.4 7.2 6.7 6.4 6.2 6.7 5.9 5.4 6.6 6.6 5.3 5.8 5.1 5.8
SG&A Expenses 31.9 27.7 27.3 29.0 28.6 28.2 25.6 24.3 23.3 21.2 19.1 18.2 16.3 15.7 14.9 14.4 13.6 11.6 9.1 6.5 5.6 4.4 3.8 3.2 3.7
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0 0
Operating Expenses 41.3 36.6 36.4 39.2 39.0 37.4 34.4 32.6 31.4 28.5 26.2 25.6 23.5 22.4 21.3 20.6 20.3 17.5 14.5 13.1 12.3 9.7 9.6 8.3 9.5
Operating Income
Operating Income (17.8) (11.3) (12.2) (14.0) (10.7) (8.6) (9.2) (8.3) (10.7) (10.9) (12.5) (13.6) (13.1) (15.0) (16.0) (15.8) (16.6) (14.7) (13.1) (13.9) (11.1) (8.3) (8.9) (8.8) (9.4)
Interest Expense (0.0) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 1.5 1.5 1.3 1.1 1.1 1.1 1.1 0.8 0.7 0.5 0.0 0.0 0.0
Interest Income 0 0 0 2.3 2.5 2.7 2.9 2.3 1.6 1.7 1.7 1.8 1.4 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3
Profitability
EBITDA (17.8) (12.3) (8.9) (11.0) (7.4) (5.4) (5.2) (5.2) (7.9) (8.1) (11.0) (11.2) (10.7) (13.2) (14.5) (14.6) (15.5) (13.6) (10.6) (11.7) (5.1) 27.8 31.8 (11.9) (15.5)
EBIT (17.8) (9.1) (9.8) (11.7) (8.2) (5.9) (6.3) (6.1) (9.1) (9.2) (12.2) (12.2) (11.7) (14.2) (15.5) (15.6) (16.5) (14.7) (11.6) (12.6) (6.1) 26.8 30.7 (12.8) (16.5)
Income Before Tax (15.9) (9.1) (9.8) (11.8) (8.2) (5.9) (6.3) (6.1) (9.1) (9.2) (12.4) (13.8) (13.2) (15.6) (16.8) (16.7) (17.6) (15.7) (12.7) (13.5) (6.8) 26.3 30.7 (12.8) (16.5)
Income Tax Expense 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 (0.0) 0.0 0.0 0 0.0 0 0 0.0 0.0 (0.0) 0.0 0.0 0.0 0.0 0.0 0.0
Net Income (15.9) (9.2) (9.8) (11.8) (8.2) (5.9) (6.3) (6.1) (9.1) (9.2) (12.4) (13.8) (13.2) (15.6) (16.8) (16.7) (17.6) (15.7) (12.7) (13.5) (6.8) 26.3 30.7 (12.9) (16.5)
Per Share Data
EPS (Basic) -0.38 -0.22 -0.24 -0.29 -0.20 -0.15 -0.16 -0.16 -0.25 -0.26 -0.35 -0.40 -0.47 -0.56 -0.61 -0.61 -0.64 -0.58 -0.68 -0.51 -0.36 1.38 0.31 -0.68 -0.87
EPS (Diluted) -0.38 -0.22 -0.24 -0.29 -0.20 -0.15 -0.16 -0.16 -0.25 -0.26 -0.35 -0.40 -0.47 -0.56 -0.61 -0.61 -0.64 -0.58 -0.68 -0.51 -0.36 1.38 0.31 -0.68 -0.87
Shares Outstanding 41.3 41.2 41.0 40.7 40.5 40.4 39.8 38.5 36.8 36.0 35.7 34.5 31.6 28.0 27.7 27.6 27.4 27.3 18.6 26.3 19.1 19.1 19.1 19.1 19.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 17.6 19.9 29.6 40.4 28 16.7 16.7 24.4 32.6 9.7 9.9 8.8 11.0 11.8 8.9 24.0 24.1 24.4 68.3 41.7 24.4 14.0
Short-Term Investments 200.3 208.2 197.9 187.1 201.3 220.5 220.4 208.8 92.7 117.5 122.0 138.3 142.9 94.0 103.9 104.6 119.7 135.0 100.0 20.0 40.0 55.0
Net Receivables 22.4 23.4 24.2 28.1 31.0 30.1 25.4 25.7 21.6 20.3 15.2 13.3 12.7 11.0 9.0 6.9 5.6 4.9 4.4 3.9 2.3 2.9
Inventory 34.9 31.6 28.9 25.1 23.6 22.0 21.7 19.4 18.7 17.4 18.9 17.9 18.1 14.8 15.3 11.6 8.5 8.0 9.4 8.5 9.8 8.3
Other Current Assets 4.0 4.4 3.3 3.3 4.5 4.5 2.6 2.8 3.0 3.5 1.9 2.1 3.0 3.0 0 0 0 0 0 0 0 0
Total Current Assets 279.2 287.5 283.9 283.9 288.4 293.8 286.8 281.2 168.6 168.4 167.9 180.4 187.7 134.6 139.2 149.9 161.1 176.3 186.3 75.5 77.8 81.5
Non-Current Assets
Property, Plant & Equipment 23.0 23.0 23.4 23.8 23.5 23.6 22.8 23.3 13.7 13.3 13.1 13.7 13.4 14.1 15.0 15.8 15.0 15.5 16.6 17.4 17.9 18.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0.7 0.8 0 0 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 1.8 1.3 0.5 0.5 1.2 1.1 0.2 0.3 0.9 0.9 0.8 1.1 1.5 1.5 1.6 1.0 0.9 0.9 0.8 1.9 0.6 0.6
Total Non-Current Assets 24.8 24.4 24.7 25.1 24.6 24.7 23.7 24.3 14.6 14.1 13.9 14.8 14.9 15.6 16.5 16.8 15.9 16.4 17.4 19.3 18.4 19.2
Total Assets 304.0 311.8 308.5 309.0 313.0 318.6 310.5 305.5 183.2 182.6 181.8 195.3 202.5 150.2 155.7 166.7 177.1 192.7 203.7 94.9 96.3 100.7
Current Liabilities
Account Payables 7.1 5.3 3.4 3.3 7.1 4.5 4.6 5.1 5.1 3.9 4.1 4.0 3.7 2.6 4.2 3.3 2.6 1.7 1.7 2.3 1.9 1.1
Short-Term Debt 1.5 1.2 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 3.1 0 0 0 2.0 0 0 0 1.3 0 0 0 0.6 0 0 0 0.4
Other Current Liabilities 18.7 19.8 17.6 0 0 17.2 0 0 0 13.2 0 0 0 10.9 0 0 0 6.9 0 2.6 0 8.8
Total Current Liabilities 27.4 26.3 22.3 20.4 22.7 25.9 22.6 19.6 18.3 20.9 18.9 16.6 14.9 17.2 16.4 13.0 10.7 11.1 9.2 11.1 6.9 11.6
Non-Current Liabilities
Long-Term Debt 9.3 9.9 0 0 0 0 0 0 0 0 0 19.6 40.3 40.2 40.0 39.9 39.9 39.8 39.6 39.5 29.5 24.4
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0.1 0 0 0 0.1 0.1 0.1 0 0 0 0 0 0 0 353.3 357.1 357.1
Total Non-Current Liabilities 9.3 9.9 10.3 10.6 11.0 11.4 10.6 10.7 0.9 1.3 1.4 21.5 42.6 43.0 43.4 43.7 43.2 43.4 43.7 397.2 391.3 386.6
Total Liabilities 36.7 36.1 32.6 31.0 33.7 37.3 33.2 30.3 19.2 22.2 20.4 38.1 57.5 60.3 59.7 56.7 53.9 54.5 52.8 408.3 398.2 398.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.8
Retained Earnings (676.9) (661.0) (651.9) (642.1) (630.3) (622.1) (616.2) (609.8) (603.7) (594.6) (585.5) (573.0) (559.2) (546.0) (530.4) (513.6) (496.9) (479.3) (463.5) (450.9) (437.4) (430.6)
Accumulated Other Comprehensive Income (0.1) 0.1 0.1 (0.1) 0.0 0.2 0.5 (0.1) (0.1) (0.0) (0.1) (0.1) (0.0) (0.1) (0.1) (0.2) (0.1) (0.0) (0.0) (0.0) 0 (0.0)
Total Stockholders' Equity 267.3 275.7 276.0 278.0 279.3 281.2 277.3 275.2 163.9 160.4 161.5 157.2 145.0 89.9 96.0 110.0 123.2 138.2 150.9 (313.4) (301.9) (297.5)
Total Liabilities & Equity 304.0 311.8 308.5 309.0 313.0 318.6 310.5 305.5 183.2 182.6 181.8 195.3 202.5 150.2 155.7 166.7 177.1 192.7 203.7 94.9 96.3 100.7
Debt Metrics
Total Debt 10.8 11.0 11.6 11.7 12.0 12.3 11.3 11.4 2.5 3.0 3.3 23.4 44.6 45.0 45.3 45.6 44.9 44.9 45.1 45.2 35.5 30.8
Net Debt (6.7) (8.9) (18.1) (28.6) (16.0) (4.4) (5.4) (13.0) (30.1) (6.7) (6.5) 14.7 33.6 33.2 36.4 21.6 20.8 20.6 (23.1) 3.5 11.1 16.8
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (15.9) (9.2) (9.8) (11.8) (8.2) (5.9) (6.3) (6.1) (9.1) (9.2) (12.4) (13.8) (13.2) (15.6) (16.8) (16.7) (17.6) (15.7) (12.7) (13.5) (6.8) 26.3 30.7 (12.9) (16.5)
Depreciation & Amortization 0.8 0.9 0.9 0.8 0.8 0.5 1.1 0.8 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0
Stock-Based Compensation 0 7.8 8.1 8.5 7.1 7.3 6.6 6.1 4.7 4.4 4.1 4.0 3.3 3.0 2.9 2.9 2.6 2.9 2.0 1.4 1.2 1.2 1.2 1.1 0.6
Change in Working Capital (2.0) 0.6 1.7 (1.0) (6.2) (3.6) 1.9 (2.9) (4.7) (3.2) (0.6) 2.5 (7.7) (1.8) (2.3) (2.0) (1.2) 2.9 (3.3) (1.6) (0.7) (2.0) (0.4) (1.1) (4.4)
Other Non-Cash Items 6.2 (1.2) (2.1) (0.9) (2.4) (2.6) (2.5) (2.1) (1.4) (3.0) 0.0 0.1 (1.1) (0.3) 0.1 (0.1) 0.2 0.1 0.1 0.1 0.1 (34.8) (39.6) 4.1 7.1
Operating Cash Flow (10.9) (1.1) (1.2) (4.4) (8.8) (4.3) 0.7 (4.1) (9.3) (9.9) (8.0) (7.5) (17.8) (13.9) (15.2) (15.0) (15.0) (8.7) (13.8) (12.0) (10.3) (8.2) (6.9) (7.8) (12.2)
Investing Activities
Capital Expenditure (0.8) (1.1) (0.6) (1.5) (0.6) (0.8) (1.1) (1.5) (2.0) (1.6) (0.7) (1.8) (0.7) (0.4) (0.6) (1.1) (0.4) (0.4) (0.3) (0.8) (0.5) (0.5) (0.6) (0.6) (0.8)
Acquisitions 0 0 0 0 0 0 0 0 0 (6.2) (17.9) (6.2) 47.6 (10.8) 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (100.4) (98.5) (68.4) (33.8) (38.6) (52.8) (77.2) (159.1) (47.8) (43.8) (72.1) (48.8) (107.6) (34.2) (73.9) (29.8) (74.8) (60.0) (95.0) 0 (5.0) (35.0) (15.0) (38.0) (9.9)
Sales/Maturities of Investments 110 90 60 50 60 55 69 45 74 50 90 55 60 45 75 45 90 25 15 20 20 21 22 38 35
Other Investing Activities 0 0 0 0 0 0 0 0 0 6.2 17.9 6.2 (47.6) 10.8 0 0 0 0 0 0 0 0.0 0 0 0
Investing Cash Flow 8.8 (9.6) (9.0) 14.7 20.9 1.3 (9.3) (115.6) 24.3 4.6 17.3 4.4 (48.4) 10.4 0.6 14.1 14.9 (35.3) (80.2) 19.2 14.5 (14.5) 6.4 (0.5) 24.2
Financing Activities
Net Debt Issuance (0.0) 0.0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 2.2 (20.0) (21.3) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) 9.9 5.0 (0.0) (0.0) (0.0) (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.5) (0.0) (0.6) 0 (1.4) 0 (2.6) 0.0 (2.1) (0.0) (2.1) (0.4) (0.6) 1.5 (0.6) 0 (0.1) 0.2 0.9 0.2 1.2 24.3 0.1 0.8 0.1
Financing Cash Flow (0.3) 1.1 (0.5) 2.1 (0.7) 3.0 0.8 111.6 8.0 5.2 (8.2) 0.9 65.3 6.3 (0.5) 0.7 (0.1) 0.4 120.5 10.2 6.1 24.3 0.1 0.8 0.1
Cash Position
Net Change in Cash (2.4) (9.7) (10.7) 12.4 11.3 (0.0) (7.7) (8.2) 23.0 (0.2) 1.1 (2.3) (0.8) 2.9 (15.1) (0.1) (0.2) (43.7) 26.5 17.4 10.4 1.6 (0.5) (7.5) 12.1
Cash at Beginning 19.9 30.4 41.1 28.8 17.5 17.4 25.2 32.6 10.4 9.9 9.5 11.8 12.6 9.7 24.8 24.9 25.2 68.8 42.3 24.8 14.5 12.9 13.4 20.9 8.8
Cash at End 17.6 20.7 30.4 41.1 28.8 17.5 17.4 24.4 33.4 9.7 10.6 9.5 11.8 12.6 9.7 24.8 24.9 25.2 68.8 42.3 24.8 14.5 12.9 13.4 20.9
Free Cash Flow (11.7) (2.3) (1.8) (5.9) (9.4) (5.1) (0.4) (5.6) (11.3) (11.5) (8.6) (9.4) (18.5) (14.2) (15.8) (16.0) (15.4) (9.1) (14.0) (12.8) (10.8) (8.8) (7.6) (8.4) (13.1)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 30.9 32.6 30.3 33.6 37.9 40.2 45.4 34.9 29.5 28.6 30.7 20.8 17.5 16.1 12.6 11.4 8.9 8.4 5.8 4.9 3.5 4.9 4.2 2.7 2.9
Gross Profit 23.5 25.3 24.2 25.2 28.3 28.8 25.2 24.2 20.7 17.7 13.7 12.0 10.4 7.4 5.4 4.8 3.8 2.9 1.3 (0.8) 1.1 1.4 0.7 (0.5) 0.1
Operating Income (17.8) (11.3) (12.2) (14.0) (10.7) (8.6) (9.2) (8.3) (10.7) (10.9) (12.5) (13.6) (13.1) (15.0) (16.0) (15.8) (16.6) (14.7) (13.1) (13.9) (11.1) (8.3) (8.9) (8.8) (9.4)
Net Income (15.9) (9.2) (9.8) (11.8) (8.2) (5.9) (6.3) (6.1) (9.1) (9.2) (12.4) (13.8) (13.2) (15.6) (16.8) (16.7) (17.6) (15.7) (12.7) (13.5) (6.8) 26.3 30.7 (12.9) (16.5)
EPS (Diluted) -0.38 -0.22 -0.24 -0.29 -0.20 -0.15 -0.16 -0.16 -0.25 -0.26 -0.35 -0.40 -0.47 -0.56 -0.61 -0.61 -0.64 -0.58 -0.68 -0.51 -0.36 1.38 0.31 -0.68 -0.87
Balance Sheet
Cash & Equivalents 17.6 19.9 29.6 40.4 28 16.7 16.7 24.4 32.6 9.7 9.9 8.8 11.0 11.8 8.9 24.0 24.1 24.4 68.3 41.7 24.4 14.0
Total Assets 304.0 311.8 308.5 309.0 313.0 318.6 310.5 305.5 183.2 182.6 181.8 195.3 202.5 150.2 155.7 166.7 177.1 192.7 203.7 94.9 96.3 100.7
Total Debt 10.8 11.0 11.6 11.7 12.0 12.3 11.3 11.4 2.5 3.0 3.3 23.4 44.6 45.0 45.3 45.6 44.9 44.9 45.1 45.2 35.5 30.8
Stockholders' Equity 267.3 275.7 276.0 278.0 279.3 281.2 277.3 275.2 163.9 160.4 161.5 157.2 145.0 89.9 96.0 110.0 123.2 138.2 150.9 (313.4) (301.9) (297.5)
Cash Flow
Operating Cash Flow (10.9) (1.1) (1.2) (4.4) (8.8) (4.3) 0.7 (4.1) (9.3) (9.9) (8.0) (7.5) (17.8) (13.9) (15.2) (15.0) (15.0) (8.7) (13.8) (12.0) (10.3) (8.2) (6.9) (7.8) (12.2)
Capital Expenditure (0.8) (1.1) (0.6) (1.5) (0.6) (0.8) (1.1) (1.5) (2.0) (1.6) (0.7) (1.8) (0.7) (0.4) (0.6) (1.1) (0.4) (0.4) (0.3) (0.8) (0.5) (0.5) (0.6) (0.6) (0.8)
Free Cash Flow (11.7) (2.3) (1.8) (5.9) (9.4) (5.1) (0.4) (5.6) (11.3) (11.5) (8.6) (9.4) (18.5) (14.2) (15.8) (16.0) (15.4) (9.1) (14.0) (12.8) (10.8) (8.8) (7.6) (8.4) (13.1)